A validation study of the new revised FIGO staging system to estimate prognosis for patients with stage IIIC endometrial cancer.

[1]  M. Kaneuchi,et al.  Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis , 2010, The Lancet.

[2]  J. Herod,et al.  Efficacy of Systematic Pelvic Lymphadenectomy in Endometrial Cancer (MRC ASTEC Trial): A Randomized Study , 2009, International Journal of Gynecologic Cancer.

[3]  V. Torri,et al.  Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. , 2009, Journal of the National Cancer Institute.

[4]  W. Creasman.  Revised FIGO staging for carcinoma of the endometrium , 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[5]  M. Parmar,et al.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study , 2009, The Lancet.

[6]  Andrea Mariani,et al.  Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. , 2008, Gynecologic oncology.

[7]  M. Maccauro,et al.  Hysteroscopic injection of tracers in sentinel node detection of endometrial cancer: a feasibility study. , 2004, American journal of obstetrics and gynecology.

[8]  Hiroki Utsunomiya,et al.  Sentinel lymph node detection in patients with endometrial cancer. , 2004, Gynecologic oncology.

[9]  Y. Taketani,et al.  Distinct lymphatic spread of endometrial carcinoma in comparison with cervical and ovarian carcinomas. , 2002, Cancer letters.

[10]  Y. Saito,et al.  Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers. , 1997, Gynecologic oncology.

[11]  J. Wharton,et al.  Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. , 1996, Gynecologic oncology.